A ctivation of the receptor for advanced glycation endproducts (RAGE) leads to a cascade of pro-inflammatory and pro-coagulant responses which are important in the pathogenesis of the vascular complications of diabetes mellitus. It is known that pro-inflammatory mechanisms underpin the development of type 2 diabetes. Our hypothesis is that RAGE may be involved in the evolution of insulin resistance in addition to mediating glucotoxic complications of diabetes mellitus. Methods To investigate the relationship between RAGE allelic variation and insulin resistance, the Gly82Ser variant and three promoter variants (-429, -374, 63 bp deletion) were studied in 480 subjects of known relationship from 89 families characterised for insulin resistance (using homeostasis model assessment [HOMA]) and for atherothrombotic risk. Carriage of the -429 C allele was weakly associated with increased insulin resistance (p=0.02) when pedigree analysis was performed using SOLAR software. Results Insulin resistance was estimated to have a heritability of 25.8% before the addition of covariates. Analysis of the relationship between RAGE and insulin resistance indicated that the -429 polymorphism reduced the unexplained heritability of insulin resistance after adjusting for covariates (age, sex, body mass index) from 17.5% of the total variance to 15.6% of the total variance. 
Introduction
It has been proposed that diabetes and cardiovascular disease have common genetic and environmental antecedents (the 'common soil hypothesis'). 1 The receptor for advanced glycation end-products (RAGE) is a candidate gene for the development of these pathologies. Initially identified as a receptor for advanced glycation end-products (AGEs), which accumulate at an accelerated rate in diabetes, activation of the multiligand RAGE in vitro results in cellular perturbation, oxidative damage and the activation of nuclear factor kappa-B (NF-κB). In turn, this leads to the expression of proteins involved in inflammatory and pro-coagulant pathways, including tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6). These pathways also lead to sustained up-regulation of RAGE in cellular models.
In both humans and rodents, increased RAGE expression is seen in vascular disease, in particular where an inflammatory component is present. 2, 3 The cellular effects of RAGE and the development of atherosclerosis can be blocked by the administration of soluble RAGE and the use of transgenic RAGE-expressing animal models. 4 Evidence links an enhanced inflammatory state with the development of both type 2 diabetes and cardiovascular disease. 5 The effects of RAGE on inflammatory pathways suggest that it may have a role in both conditions. The aim of this study was to determine whether genetic variation in the RAGE gene contributes to insulin resistance in non-diabetic healthy white families of known pedigrees.
Research design and methods
The 537 subjects for this study were recruited from the community-based Family Health Authority Register in Leeds. Full details of recruitment, sample collection, population characteristics and analysis for this study are reviewed in Freeman et al. 6 PCR-RFLP was performed as previously described. 7 
Statistical analysis
Homeostasis Model Assessment (HOMA) is a measure of relative insulin resistance. HOMA is estimated from the fasting insulin and glucose levels and assumes that a normal weight healthy subject aged less than 35 years has an insulin resistance of unity. 8 In this population HOMA values were approximately normally distributed after log transformation, and the transformed values were used in all analyses. For each polymorphism subjects were categorised into two groups according to genotype (combining heterozygotes and homozygotes for the rarer allele). Association with HOMA levels was investigated using random effects models which were used to model HOMA values (after log transformation), treating genotype as a fixed effect and family as a random effect to allow for familial correlation.
Hardy-Weinberg equilibrium
Each polymorphism was tested for Hardy-Weinberg equilibrium using a chi-squared goodness-of-fit test using Stata (Stata Statistical Software: Release 7.0. College Station, TX: Stata Corporation). This was applied to the data set as a whole, ignoring relationships between individuals, and was repeated in probands only.
Power calculations
Approximate power calculations for the association analysis were carried out based on t-tests, thus ignoring the familial clustering of the data. Allowing for familial clustering in the analysis, as we have done, slightly reduces power by correcting the standard errors of the parameter estimates.
Haplotype analysis
Associations between insulin resistance and haplotypes within the RAGE gene were investigated using the qhapipf program within Stata. 9 Haplotype frequencies are estimated using an EM-algorithm to resolve phase and the quantitative trait is regressed on covariates constructed from these. This analysis also allows the joint regression of the trait on multiple genotypes (assuming phase is unimportant). The analysis ignores the familial nature of the data.
Heritability
Variance components analysis was undertaken with the SOLAR software package (Southwest Foundation for Biomedical Research). 10 Initially a polygenic model was fitted to estimate the overall heritability (i.e. the proportion of variance explained by polygenic effects). This analysis was repeated allowing for covariates (age, sex and body mass index [BMI] ). Genotype (as described above) was also included as a covariate in the model, and the effect of allowing for genotype on the estimate of heritability was examined. Finally, multipoint quantitative trait linkage analysis was performed, treating the polymorphisms as three markers in the RAGE gene (Gly82Ser, -429 T/C and a combined 'threeallele' marker for -374 T/A and the deletion).
Results
Complete data were available on 480 subjects recruited from 89 pedigrees from 133 households. The median age of the subjects was 40 years (range 16-88 years). The median BMI was 24.7 kg m -2 . The Gly82Ser genotypes occurred with the following frequencies: 420 (87.5%) GG, 59 (12.3%) GS and one (0.2%) SS. The 374 genotypes occurred with frequencies of 306 (64.6%) TT, 153 (32.3%) TA and 15 (3.2%) AA and the locus was deleted in four (0.8%) subjects. The 429 genotypes occurred with frequencies of 315 (65.9%) TT, 156 (32.6%) TC and seven (1.5%) CC. The polymorphisms were in strong linkage disequilibrium (table 1). All genotypes were in HardyWeinberg equilibrium except for the -429 C allele, which had fewer CC homozygotes than expected.
From the initial random effects modelling, there was no evidence of association between phenotype and Gly82Ser (p=0.49), -429 (p=0.08), -374 (p=0.46) and the deletion (p=0.91).
Power
For the two more common polymorphisms (-429 and -374), the study had greater than 80% power to detect a fairly modest difference of 0.3 standard deviations according to genotype. However, the observed difference according to -429 genotype was even smaller than this (0.05 units after logarithmic transformation, or 0.2 standard deviations), and the power to detect a difference of this size was only 50% (assuming a two-sided test with 5% significance level). The power to detect association with the less common Gly82Ser polymorphism was lower (80% power to detect a difference of 0.4 standard deviations).
Haplotype and multi-locus analysis
Because of the strong linkage disequilibrium between the markers, only four distinct haplotypes accounted for 99% of all chromosomes. These haplotypes contained no variant (57%), -374 variant only (19%), -429 variant only (17%) or Gly82Ser variant only (6%). In other words, the variants were virtually never seen together on the same chromosome. Analysis of haplotypes and multiple loci jointly revealed no further evidence of association with the trait.
Heritability analysis
The overall heritability of insulin resistance as measured by HOMA was 25.8% before the addition of covariates. Age, sex and BMI were included as covariates in the model and accounted for 21.0% of the trait variability. Since BMI is itself highly heritable it accounted for some of the heritability of the trait ( type explains a small proportion of the heritability of insulin resistance, reducing the estimated remaining heritability from 17.5% to 15.6%, with the remaining 15.6% of the total phenotypic variance attributable to other genetic effects unrelated to BMI (table 2) . Multipoint linkage analysis showed no evidence of linkage to this region (maximum LOD score of zero).
Discussion
We investigated the relationship between functional polymorphisms of the RAGE gene and their contribution to insulin resistance. This study suggests a possible relationship between possession of the -429 C allele and insulin resistance in individuals as measured by HOMA. Power for linkage studies is generally much lower than for association, so the lack of evidence for linkage may well be attributable to low power of the study to detect a modest effect. The small contribution of each gene to the polygenic nature of insulin resistance means that studies like the current one are relatively underpowered to detect such small contributions. Ideally, the investigation should now be repeated in a much larger population. The fact that the -429 allele is not in Hardy-Weinberg equilibrium could be due to genotyping error, although a section of genotyping was repeated and several families were checked for recombinants. Alternatively, this may merely reflect a skewed genotype distribution that is known to occur in family studies because of the family relationships. Previous studies suggest that allelic variation within key gene regions of RAGE may affect disease outcome. In particular, the Gly82Ser polymorphism in the ligand-binding domain has been shown to increase generation of inflammatory mediators and the -374 T/A and -429 T/C promoter polymorphisms increase reporter gene expression and alter transcription factor binding. 11 This suggests a role for allelic variants of RAGE in the pathogenesis of inflammatory diseases. In our study, no evidence for the linkage of the RAGE gene region to insulin resistance was found, perhaps due to power limitations or because the markers have low polymorphism information content.
RAGE has not been implicated before in the pathogenesis of type 2 diabetes mellitus and insulin resistance. However, recent studies suggest some interactions between RAGE and diabetes as thiazolidinediones reduce RAGE expression in vitro 12 and blocking RAGE-ligand interaction inhibits the late stages of autoimmune diabetes. 13 The proposed relationship between over-expression of RAGE and insulin resistance could result from the cascade of cytokines elaborated through RAGE, including the activation of NF-κB and the production of TNF-α and interleukin-6 (IL-6), which has been shown to contribute to the onset of type 2 diabetes. 5 The observation that RAGE may contribute to both conditions could provide a genetic link between the development of insulin resistance in early life and the development of type 2 diabetes mellitus and vascular disease in middle-aged subjects.
In summary, our preliminary results support the hypothesis that genetic variation in RAGE may have a minor role in the development of insulin resistance in the white population. Further studies are required to confirm this association. 
